Magazine article from our research archive:
|
|
3M Collaborates with IDRI on Vaccine Adjuvants
- Article from:
-
Biopharm International
- Article date:
-
June 1, 2008
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 2008. Provided by ProQuest LLC. (Hide copyright information)
|
3M Drug Delivery Systems (St. Paul, MN) has signed a non-exclusive license agreement with the Infectious Disease Research Institute (IDRI, Seattle, WA) in support of vaccine research in developing countries. Under the agreement, 3M will donate its patented ...
Related newspaper, magazine, and journal articles:
|
3M Collaborates with IDRI on Vaccine Adjuvants
Biopharm International;
July 1, 2008 ;
86 words
......receptor (TLR) immune response modifier compounds. 3M's TLR immune response modifier compounds, which may be useful as vaccine adjuvants, will be used by IDRI to research new vaccines. Vaccine adjuvants are known to help boost the...
|
|
New Book Addresses Issues In Relation To Existing Vaccine Adjuvants, Those...
M2 Presswire;
October 26, 2007 ;
700+ words
......Addresses Issues In Relation To Existing Vaccine Adjuvants, Those In Clinical Trials, And Those...c72858) has announced the addition of Vaccine Adjuvants and Delivery Systems to their offering...these issues in relation to existing vaccine adjuvants, those in clinical trials, and ...
|
|
Japanese Inventors Develop Anti-Endotoxin Agents
US Fed News Service, Including US State News;
September 3, 2008 ;
223 words
......Mamoru Suzuki, both of Ibaraki, Japan, have developed a vaccine adjuvants. According to the U.S. Patent & Trademark Office...preventive or remedy for infection, an anti-endotoxin agents, a vaccine adjuvants and a growth promoter each comprising a sugar cane-derived...
|
|
Japanese Inventors Develop Infection Preventives
US Fed News Service, Including US State News;
December 20, 2006 ;
249 words
......preventives/remedies for infection, anti-endtoxin agents, vaccine adjuvants and growth promoters. According to the U.S. Patent &...preventive or remedy for infection, an anti-endotoxin agents, a vaccine adjuvants and a growth promoter each comprising a sugar cane-derived...
|
|
Stakeholder Opinions - Vaccine adjuvants - uncertainties rule.
M2 Presswire;
November 6, 2008 ;
463 words
......2008-www.companiesandmarkets.com: Stakeholder Opinions - Vaccine adjuvants - uncertainties rule(C)1994-2008 M2 COMMUNICATIONS LTD...companiesandmarkets.com adds new report: Stakeholder Opinions - Vaccine adjuvants - uncertainties rule Introduction Adjuvants are coming...
|
|
Reheis Upgrades Website.(Brief Article)
Chemical Market Reporter;
November 20, 2000 ;
61 words
......information on the company's products and their applications, and includes a section on its global agent and distributor network. Products covered include antacid and antiperspirant actives, aluminum-based vaccine adjuvants and potassium chloride.
|
|
WIPO: Inventors in Indiana Develop Vaccine Adjuvants for Diseases
US Fed News Service, Including US State News;
October 22, 2008 ;
239 words
......According to an abstract posted by the World Intellectual Property Organization, the invention relates to "vaccines and vaccine adjuvants, useful in the treatment and/or prevention of infection and diseases associated with infectious pathogens, such as tetanus...
|
|
Endogen Awarded $230,000 Phase II SBIR Grant.
PR Newswire;
October 21, 1998 ;
621 words
......and the investigation of recombinant porcine cytokines as vaccine adjuvants. Endogen's cytokine ELISA test kits and reagents are widely...investigating the use of recombinant porcine cytokines as vaccine adjuvants will also be performed under the Phase II grant. If the...
|
|
Ascentia Biomedical Corporation Further Defines Option Agreement With...
PR Newswire;
August 31, 2005 ;
605 words
......major goal of the biotechnology industry is to identify the vaccine adjuvants, called 'danger signals,' which elicit an immune response...the treatment of sepsis and autoimmune diseases and as vaccine adjuvants. About Ascentia Biomedical Corporation Our focus is SOLUTIONS...
|
|
Bioject Advances in Vaccine Delivery With Biojector(R) 2000.
PR Newswire;
October 9, 2006 ;
700+ words
......PRNewswire-FirstCall/ -- Studies presented at the Modern Vaccine Adjuvants et Delivery Systems Conference and at the AIDS Vaccine...cancer and AIDS vaccines. In a study presented at the Modern Vaccine Adjuvants et Delivery Systems Conference held September 2006 at the...
|
|
Japanese Inventors Develop Remedies for Infection
US Fed News Service, Including US State News;
June 14, 2008 ;
225 words
......According to the U.S. Patent & Trademark Office: "A preventive or remedy for infection, an anti-endotoxin agents, a vaccine adjuvants and a growth promoter each comprising a sugar cane-derived extract as an active ingredient which agent is safe to man and...
|
|
3M Inks License Pact with Avant.
Health & Beauty Close-Up;
June 13, 2008 ;
437 words
......3M s patented TLR immune response modifier compounds, which may be useful as vaccine adjuvants, will be used by Celldex to develop...agonists that have shown promise as vaccine adjuvants. There are a variety of assets in...
|
|
Immune Stimulation for the Treatment of Papilloma
The Annals of Otology, Rhinology & Laryngology;
September 1, 2005 ;
700+ words
......that have shown efficacy against tumors as monotherapy, as vaccine adjuvants, and in combination with chemotherapies. We examined the...mammalian immune system.5 CpGs are extremely effective vaccine adjuvants in mammals and have been tested in the treatment of several...
|
|
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists - Out...
M2 Presswire;
November 20, 2008 ;
410 words
......includes agonists, antagonists as well as vaccines and vaccine adjuvants. Among the companies active in the R&D field of TLR agonists...Covered: TLR Agonists TLR Antagonists TLR Vaccines and TLR Vaccine Adjuvants About La Merie For more information visit http://www.researchandmarkets...
|
|
How common vaccine ingredient protects against infectious diseases
The Hindustan Times;
May 22, 2008 ;
433 words
......alum (aluminum hydroxide/phosphate formulations), the only vaccine adjuvants licensed for general use in the United States. Adjuvants...adjuvant function and should facilitate the design of new vaccine adjuvants. Published by HT Syndication with permission from Asian...
|
See all results.
Or, try our
Advanced Search.
|